Back to discover
Disease

Bulimia

Late-stage therapeutic developmentEmerging research
3
Publications
13
Clinical trials
1
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

The emerging role of glucagon-like peptide 1 in binge eating.

Research2024-05-09The Journal of endocrinology

Not niche: eating disorders as an example in the dangers of overspecialisation.

Research2024-03-01The British journal of psychiatry : the journal of mental science

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q2 2028.
Major developments
Upcoming trial readoutImportant
Results expected Q2 20282026-06-22
Clinical Milestones1View
Results expected 1
Activity timeline1

Clinical trials

11 sponsors · 1 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
13
All trials
1
Active
4
Late-stage
6
Completed
Recruiting

MDMA Assisted Therapy for Bulimia Nervosa: A Treatment Development Protocol

Phase 1 · Recruiting · Icahn School of Medicine at Mount Sinai
Recently completed

Research activity

3 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20232024
Most influential

Not niche: eating disorders as an example in the dangers of overspecialisation.

The British journal of psychiatry : the journal of mental science · 2024 · 28 cites

The emerging role of glucagon-like peptide 1 in binge eating.

The Journal of endocrinology · 2024 · 24 cites
Recent publications

Not niche: eating disorders as an example in the dangers of overspecialisation.

The British journal of psychiatry : the journal of mental science · 2024 · 28 cites

The emerging role of glucagon-like peptide 1 in binge eating.

The Journal of endocrinology · 2024 · 24 cites
Major themes8
  • Bulimia2
  • Anorexia Nervosa1
  • Binge-Eating Disorder1
  • Bulimia Nervosa1
  • Feeding and Eating Disorders1
  • Glucagon-Like Peptide 11
  • Glucagon-Like Peptide-1 Receptor1
  • Glucagon-Like Peptide-1 Receptor Agonists1
Leading journals3
  • Obesity (Silver Spring, Md.)1
  • The British journal of psychiatry : the journal of mental science1
  • The Journal of endocrinology1
Leading researchers8
  • Balantekin KN1
  • Egbert AH1
  • Fitzsimmons-Craft EE1
  • Grilo CM1
  • Haynos AF1
  • Jastreboff AM1
  • Kretz MJ1
  • Levinson CA1
Affiliations (unnormalised)6
  • Center for Ingestive Behavior Research1
  • Northwestern University1
  • School of Public Health and Health Professions1
  • University of Connecticut1
  • University of Louisville1
  • Virginia Commonwealth University1

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.